Pharmacology, Toxicology and Pharmaceutical Science
Anti-Inflammatory Drug
62%
Antiapoptotic
33%
Antioxidant
100%
B Cell Lymphoma
29%
Bioflavonoid
34%
Brain Injury
29%
Brain Ischemia
29%
Bromocriptine Mesilate
29%
Cardiobacterium
29%
Catalepsy
32%
Combination Therapy
32%
Cytokine
97%
Developmental Toxicity
29%
Diabetes Mellitus
62%
Diabetic Neuropathy
29%
Diet Induced Obesity
29%
Digestant
29%
Doxorubicin
29%
Dyslipidemia
37%
Endothelial Dysfunction
59%
Epitope
59%
Essential Oil
29%
Eugenol
29%
Fluorouracil
29%
Glibenclamide
29%
Hemorrhagic Fever
29%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
29%
Inflammation
33%
Ischemia
29%
Juniper
37%
Kidney Injury
29%
Liver Injury
29%
Marburg Virus
29%
Messenger RNA
83%
Methanol
56%
Moringa oleifera
29%
Neuroprotective Agent
60%
Nigella sativa
29%
Oxaliplatin
29%
Parkinson's Disease
74%
Rabbit Model
29%
Rat Model
34%
Roflumilast
29%
Rotenone
44%
Streptozotocin
37%
Streptozotocin-Induced Diabetes Mellitus
42%
Toll Like Receptor 4
32%
Tumor Necrosis Factor
39%
Ulcerative Colitis
29%
Wistar Rat
69%
Biochemistry, Genetics and Molecular Biology
Absorption
14%
Acetic Acid
14%
Allergenicity
9%
AMP-activated Protein Kinase
29%
Antibacterial Activity
29%
Antidiabetic Activity
29%
Antigenicity
19%
Artemisia
26%
Binding Affinity
29%
Body Weight
14%
Body Weight Gain
14%
Bovine Serum Albumin
29%
Cancer Cell
14%
Cardiobacterium
29%
Catechin
14%
Cholesterol Blood Level
18%
Circular Dichroism
14%
Conformation
14%
Docking (Molecular)
14%
Doxorubicin
29%
Drug Megadose
14%
Dyslipidemia
67%
Enzyme
29%
Enzyme Activity
22%
Fibroblast
14%
Flavonoid
12%
Glucose Blood Level
20%
Gram Negative Bacterium
14%
Immunocompetent Cell
19%
Insulin Blood Level
10%
Interactions with DNA
29%
Lipid Profile
29%
Liver Weight
14%
Low-Density Lipoprotein
14%
Minimum Inhibitory Concentration
14%
Moringa oleifera
29%
Naringenin
29%
Oxidative Stress
21%
Protein Interaction
14%
Protozoon
9%
Quenching (Fluorescence)
29%
Quercetin
9%
Rat Model
14%
Rhodnius prolixus
29%
Streptozotocin
59%
TLR4
19%
Triatominae
29%
Very Low-Density Lipoprotein
14%
Wistar Rat
65%
Zone of Inhibition
14%
Immunology and Microbiology
Allergenicity
19%
B Cell
26%
Binding Affinity
24%
Body Mass
14%
Body Weight Gain
14%
Bovine Serum Albumin
14%
Cancer Cell
7%
Cancer Cell Line
7%
Chagas Disease
9%
Complement Factor B
9%
Cytotoxicity
7%
Drug Megadose
16%
Epitope
56%
Fat Pad
14%
Fibroblast Cell Line
7%
Glucagon
6%
Human Leukocyte Antigen
9%
Immune Response
41%
Immunogenicity
13%
Insulin
6%
Interactions with DNA
14%
Interferon
9%
Kidney Tissue
29%
Liver Weight
14%
Low Drug Dose
6%
Low-Density Lipoprotein
29%
Marburgvirus
29%
Molecular Docking
18%
Molecular Model
29%
Normal Human
7%
Peptides
37%
Pharmacokinetic
7%
Prostaglandin E2
9%
Protein Interaction
7%
Red Yeast Rice
29%
Retroperitoneal Fat
14%
Rhodnius prolixus
29%
Somatostatin
6%
T Cell
27%
Thymus
7%
Tissue Level
9%
TLR4
9%
Transcription Factor Nrf2
6%
Triatominae
29%
Trypanosoma cruzi
9%
Tryptophan
7%
Urea Nitrogen Blood Level
9%
Vascular Endothelium
29%
Viral Disease
13%
Wistar Rat
21%